Open Actively Recruiting

Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors

About

Brief Summary
Primary Purpose
Treatment
Study Type
Interventional
Phase
Phase 1

Eligibility

Gender
All
Healthy Volunteers
No
Minimum Age
18 Years
Maximum Age
N/A

Inclusion Criteria:

Exclusion Criteria:

Join this Trial

Share:
Study Stats
Protocol No.
21-001156
Category
Colorectal Cancer
Esophageal Cancer
Liver Cancer
Lung Cancer
Other Cancer
Pancreatic Cancer
Prostate Cancer
Stomach Cancer
Contact
LISA-MARIA YONEMOTO
Location
  • UCLA Santa Monica
For Providers
NCT No.
NCT05055609
For detailed technical eligibility, visit ClinicalTrials.gov.